These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 15534187)

  • 1. Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias.
    Solis C; Martinez-Bermejo A; Naidich TP; Kaufmann WE; Astrin KH; Bishop DF; Desnick RJ
    Arch Neurol; 2004 Nov; 61(11):1764-70. PubMed ID: 15534187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous hydroxymethylbilane synthase knock-in mice provide pathogenic insights into the severe neurological impairments present in human homozygous dominant acute intermittent porphyria.
    Yasuda M; Gan L; Chen B; Yu C; Zhang J; Gama-Sosa MA; Pollak DD; Berger S; Phillips JD; Edelmann W; Desnick RJ
    Hum Mol Genet; 2019 Jun; 28(11):1755-1767. PubMed ID: 30615115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of acute intermittent porphyria: mutations and polymorphisms in the human hydroxymethylbilane synthase gene.
    Astrin KH; Desnick RJ
    Hum Mutat; 1994; 4(4):243-52. PubMed ID: 7866402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
    Sassa S; Zalar GL; Kappas A
    J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation.
    De Siervi A; Rossetti MV; Parera VE; Astrin KH; Aizencang GI; Glass IA; Batlle AM; Desnick RJ
    Am J Med Genet; 1999 Oct; 86(4):366-75. PubMed ID: 10494093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
    J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute intermittent porphyria--impact of mutations found in the hydroxymethylbilane synthase gene on biochemical and enzymatic protein properties.
    Ulbrichova D; Hrdinka M; Saudek V; Martasek P
    FEBS J; 2009 Apr; 276(7):2106-15. PubMed ID: 19292878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between biochemical findings, structural and enzymatic abnormalities in mutated HMBS identified in six Israeli families with acute intermittent porphyria.
    Ulbrichova D; Schneider-Yin X; Mamet R; Saudek V; Martasek P; Minder EI; Schoenfeld N
    Blood Cells Mol Dis; 2009; 42(2):167-73. PubMed ID: 19138865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intermittent porphyria: a single-base deletion and a nonsense mutation in the human hydroxymethylbilane synthase gene, predicting truncations of the enzyme polypeptide.
    Lee GY; Astrin KH; Desnick RJ
    Am J Med Genet; 1995 Aug; 58(2):155-8. PubMed ID: 8533808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why is the patient with acute intermittent porphyria not light sensitive?
    Wetterberg L; Thunell S; Zetterlund P
    Acta Derm Venereol Suppl (Stockh); 1982; 100():73-4. PubMed ID: 6962637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
    Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP).
    Solis C; Lopez-Echaniz I; Sefarty-Graneda D; Astrin KH; Desnick RJ
    Mol Med; 1999 Oct; 5(10):664-71. PubMed ID: 10602775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual activity of human porphobilinogen deaminase with R167Q or R167W mutations: an explanation for survival of homozygous and compound heterozygous acute intermittent porphyrics.
    Edixhoven-Bosdijk A; de Rooij FW; de Baar-Heesakkers E; Wilson JH
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):861-6. PubMed ID: 12699244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations.
    Clavero S; Bishop DF; Haskins ME; Giger U; Kauppinen R; Desnick RJ
    Hum Mol Genet; 2010 Feb; 19(4):584-96. PubMed ID: 19934113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An odd case of heteroallelic acute intermittent porphyria in the Argentinean population.
    Piñeiro Pauwels MB; Gerez EN; Martinez MC; Melito VA; Parera VE; Batlle A; Rossetti MV
    Cell Mol Biol (Noisy-le-grand); 2013 Mar; 59 Suppl():OL1855-60. PubMed ID: 23522335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute intermittent porphyria: the in vitro expression of mutant hydroxymethylbilane synthase.
    Ong PM; Lanyon WG; Graham G; Hift RJ; Halkett J; Moore MR; Connor JM
    Mol Cell Probes; 1997 Aug; 11(4):293-6. PubMed ID: 9281416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria.
    Gross U; Puy H; Doss M; Robreau AM; Nordmann Y; Doss MO; Deybach JC
    Mol Cell Probes; 1999 Dec; 13(6):443-7. PubMed ID: 10657149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uroporphyrinogen synthase in erythrocytes in acute intermittent porphyria: new pathobiochemical aspects (author's transl)].
    Doss M; von Tiepermann R
    J Clin Chem Clin Biochem; 1978 Feb; 16(2):111-8. PubMed ID: 624910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel HMBS founder mutation and significant intronic polymorphism in Spanish patients with acute intermittent porphyria.
    Guillén-Navarro E; Carbonell P; Glover G; Sánchez-Solís M; Fernández-Barreiro A
    Ann Hum Genet; 2004 Sep; 68(Pt 5):509-14. PubMed ID: 15469427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.
    Lindberg RL; Porcher C; Grandchamp B; Ledermann B; Bürki K; Brandner S; Aguzzi A; Meyer UA
    Nat Genet; 1996 Feb; 12(2):195-9. PubMed ID: 8563760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.